In rhabdomyosarcoma (RMS), miR-7 exerts an anti-tumor effect by targeting mitochondrial proteins SLC25A37 and TIMM50, ultimately inducing necrosis35. This evidence concerns the gene SLC25A37 and rhabdomyosarcoma.